Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

NRXS

Neuraxis (NRXS)

Neuraxis Inc
Da:
Ordina per:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:NRXS
DataOraFonteTitoloSimboloCompagnia
20/03/202513:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]AMEX:NRXSNeuraxis Inc
12/03/202514:00GlobeNewswire Inc.NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025AMEX:NRXSNeuraxis Inc
11/03/202515:30InvestorsHub NewsWire$PYPD - PolyPid Hits Major Milestone: Completes Trial Enrollment, Poised for Potential Breakthrough in $10 Billion Surgical Infection MarketAMEX:NRXSNeuraxis Inc
12/02/202514:21Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:NRXSNeuraxis Inc
12/02/202506:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:NRXSNeuraxis Inc
05/02/202522:33Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]AMEX:NRXSNeuraxis Inc
21/01/202519:45GlobeNewswire Inc.UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple StatesAMEX:NRXSNeuraxis Inc
21/01/202515:00GlobeNewswire Inc.NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple StatesAMEX:NRXSNeuraxis Inc
13/01/202515:00GlobeNewswire Inc.NeurAxis Inc. Issues Letter to ShareholdersAMEX:NRXSNeuraxis Inc
08/01/202515:21Edgar (US Regulatory)Form 8-K - Current reportAMEX:NRXSNeuraxis Inc
08/01/202515:00GlobeNewswire Inc.NeurAxis Inc. Announces Strong Preliminary Unaudited Fourth Quarter 2024 Results; Revenues Increased 50% Year-Over-YearAMEX:NRXSNeuraxis Inc
06/01/202515:00GlobeNewswire Inc.NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025AMEX:NRXSNeuraxis Inc
13/12/202422:00Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:NRXSNeuraxis Inc
10/12/202415:00GlobeNewswire Inc.NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic ConstipationAMEX:NRXSNeuraxis Inc
12/11/202414:10GlobeNewswire Inc.NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in RevenuesAMEX:NRXSNeuraxis Inc
05/11/202415:00GlobeNewswire Inc.NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024AMEX:NRXSNeuraxis Inc
04/11/202415:00GlobeNewswire Inc.NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable MarketAMEX:NRXSNeuraxis Inc
29/10/202414:00GlobeNewswire Inc.NeurAxis Announces Capital Blue Cross Medical Policy Coverage for PENFS, effective October 1st 2024AMEX:NRXSNeuraxis Inc
22/10/202415:00GlobeNewswire Inc.NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field StimulationAMEX:NRXSNeuraxis Inc
19/09/202415:00GlobeNewswire Inc.NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024AMEX:NRXSNeuraxis Inc
27/08/202415:00GlobeNewswire Inc.NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024AMEX:NRXSNeuraxis Inc
13/08/202415:00GlobeNewswire Inc.NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024AMEX:NRXSNeuraxis Inc
09/08/202414:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NRXSNeuraxis Inc
09/08/202414:00GlobeNewswire Inc.NeurAxis Reports Second Quarter 2024 Financial ResultsAMEX:NRXSNeuraxis Inc
05/08/202415:00GlobeNewswire Inc.NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday, August 9, 2024AMEX:NRXSNeuraxis Inc
07/06/202415:00GlobeNewswire Inc.NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit DisclosureAMEX:NRXSNeuraxis Inc
22/05/202414:00GlobeNewswire Inc.NeurAxis Reports First Quarter 2024 Financial ResultsAMEX:NRXSNeuraxis Inc
21/05/202415:00GlobeNewswire Inc.NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024AMEX:NRXSNeuraxis Inc
16/05/202415:00GlobeNewswire Inc.NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in FloridaAMEX:NRXSNeuraxis Inc
15/05/202422:30GlobeNewswire Inc.NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024AMEX:NRXSNeuraxis Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:NRXS